Earlier this month, we responded to HM Treasury's 'Financing Growth in Innovative Firms' consultation, which forms part of the Government's Patient Capital Review. Over the long-term, this exercise aims to improve access to capital for innovative firms.
The review cuts across a wide array of themes, and the Treasury consulted on the strengths and weaknesses of the existing investment ecosystem, the barriers holding back an effective supply of patient capital, and whether existing tax measures are cost effective.
Our response highlighted the vibrancy of the industry, and the crucial role played by EIS and SEIS in supporting the investment of patient capital.
We also suggested a number of improvements that could be made in future.
These were on made on the basis of our views that:
Our team will be following the progress and outcomes of the consultation closely, and look forward to discussing its impact with clients and industry partners.
Almost done…
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly